Corneal flap complications in refractive surgery: Part 2: postoperative treatments of diffuse lamellar keratitis in an experimental animal model

J Cataract Refract Surg. 2003 Apr;29(4):803-7. doi: 10.1016/s0886-3350(02)01915-6.

Abstract

Purpose: To induce diffuse lamellar keratitis (DLK) and investigate a prophylactic treatment with pharmacological agents.

Setting: Magill Research Center for Vision Correction, Storm Eye Institute, Charleston, South Carolina, USA.

Methods: In 100 eyes of 50 Dutch Belted rabbits, a nasal corneal flap was cut and the interface inoculated with Pseudomonas aeruginosa lipopolysaccharide endotoxin (n = 50) or Palmolive Ultra soap (n = 50). The eyes were randomly assigned to treatment with a mast-cell stabilizer, a nonsteroidal antiinflammatory drug (NSAID), a fluoroquinolone antibiotic agent, a corticosteroid, or left without treatment as a control. Slitlamp examinations and photographs were performed 1, 3, 5, and 7 days postoperatively, and DLK was graded by a masked observer from 0 (no DLK) to stage 4.

Results: At the end of the study, 80 eyes were available for evaluation. Ninety-four percent of the untreated eyes developed DLK compared to 56% of eyes treated with NSAIDs and 63% of eyes treated with steroids (P<.05, Fisher exact test). The DLK rates with the mast-cell stabilizer and fluoroquinolone antibiotic agent were 86% and 76%, respectively. The DLK incidence in the latter 2 groups was not significantly different from that in the control eyes (P>.05, Fisher exact test).

Conclusions: Postoperative prophylactic treatment with NSAIDs and corticosteroids led to a statistically significantly lower incidence of postoperative DLK. The study demonstrated that corticosteroids and NSAIDs can be used to treat DLK after LASIK. While steroids are a generally accepted treatment for DLK, NSAIDS may offer an additional potent modality.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Corneal Stroma / surgery
  • Disease Models, Animal*
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use*
  • Keratitis / drug therapy*
  • Keratitis / etiology
  • Keratomileusis, Laser In Situ / adverse effects
  • Ketorolac Tromethamine / administration & dosage
  • Ketorolac Tromethamine / therapeutic use
  • Lipopolysaccharides
  • Nedocromil / administration & dosage
  • Nedocromil / therapeutic use
  • Ofloxacin / administration & dosage
  • Ofloxacin / therapeutic use
  • Ophthalmic Solutions / administration & dosage
  • Ophthalmic Solutions / therapeutic use
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / etiology
  • Prednisolone / administration & dosage
  • Prednisolone / analogs & derivatives*
  • Prednisolone / therapeutic use
  • Pseudomonas aeruginosa
  • Rabbits
  • Refractive Surgical Procedures
  • Surgical Flaps / adverse effects*

Substances

  • Anti-Infective Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Glucocorticoids
  • Lipopolysaccharides
  • Ophthalmic Solutions
  • Nedocromil
  • Ketorolac Tromethamine
  • prednisolone acetate
  • Prednisolone
  • Ofloxacin